Signpost Capital Advisors’s Medicines Co MDCO Stock Holding History

Signpost Capital Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.68M	Sell	34,423 -76,460	-69%	-$3.49M	4.92%	5
2016 Q4	$3.76M	Sell	110,883 -40,473	-27%	-$1.44M	4.61%	7
2016 Q3	$5.71M	Sell	151,356 -68,642	-31%	-$2.59M	4.81%	8
2016 Q2	$7.4M	Sell	219,998 -50,208	-19%	-$1.77M	3.9%	10
2016 Q1	$8.58M	Buy	270,206 +94,014	+53%	+$3.07M	4.02%	12
2015 Q4	$6.58M	Hold	176,192	–	–	1.76%	19
2015 Q3	$6.69M	Sell	176,192 -78,399	-31%	-$2.75M	2.3%	15
2015 Q2	$7.28M	Buy	+254,591	New	+$7.09M	2.07%	11

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Signpost Capital Advisors's MDCO Position: Q1 2017 in Review

Signpost Capital Advisors reduced its Medicines Co (MDCO) stake by 69% in Q1 2017, selling an estimated $3.49M and leaving 34,423 shares worth $1.68M. The position accounts for 4.92% of the portfolio, ranked #5.

Signpost Capital Advisors first reported a position in MDCO in Q2 2015 and has held it in 8 quarters since. The position peaked at $8.58M in Q1 2016. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

Signpost Capital Advisors held 34,423 shares of Medicines Co worth $1.68M as of Q1 2017.
Signpost Capital Advisors sold 76,460 Medicines Co shares in Q1 2017, an estimated $3.49M.
Medicines Co made up 4.92% of Signpost Capital Advisors's portfolio in Q1 2017, its #5 holding.
Signpost Capital Advisors first reported a position in Medicines Co in Q2 2015 and has held it in 8 quarters since.
Signpost Capital Advisors's Medicines Co position peaked at $8.58M in Q1 2016.
220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on Signpost Capital Advisors's 13F filing for Q1 2017, filed 1 May 2017.